-
UK Researcher Leverages Artificial Intelligence to Understand Mesothelioma
In the quest for a cure for malignant mesothelioma, scientists have long been at a considerable disadvantage. The rare form of asbestos-related cancer’s latency period allows it to grow within the body unnoticed for decades until it is extremely advanced, and traditional treatment approaches have proven insufficient. But researchers in the United Kingdom are leveraging
-
Minnesota Man’s Mesothelioma Lawsuit to be Heard in May
COVID-19 impacted many mesothelioma lawsuits, including the wrongful death claim filed by Carol Backe against Conwed Corporation. Though the trial was originally scheduled for February, its date was pushed back to May. The delay is one of many that the Backe family have faced since Gene “Randy” Backe was diagnosed with the fatal disease in
-
Researchers Confirm Role of PD-L1 in Peritoneal Mesothelioma
Malignant mesothelioma is one of the rarest cancers, with only about 3,500 people diagnosed with the disease in the United States each year. Of those 3,500, only about 20%, or 700 patients, are diagnosed with peritoneal mesothelioma, a form of the disease that impacts the lining of the peritoneal cavity. The extremely small number of
-
Phase Three Clinical Trial Opens for Mesothelioma Patient Enrollment
The greatest hope for extended survival in malignant mesothelioma lies in the development of new treatment protocols, but there’s a long road from innovation to approval. New drugs need to go through a rigorous clinical testing process that ensures both effectiveness and safety. One of the more promising treatments under review is the immunotherapy drug
-
UK Study Reveals Mesothelioma Patients Should Get 2nd COVID-19 Vaccine on Schedule
Mesothelioma patients and others diagnosed with cancer have spent the last year taking special precautions, avoiding contact with loved ones and others in order to protect against the risks of the coronavirus. Now several approved vaccines have promised an end to the danger, but a study is emphasizing the need for these patients to be
-
Acupuncture Study Delivers Useful News for Relief of Mesothelioma Pain
An eye-opening study conducted by researchers from the Memorial Sloan Kettering Cancer Center in New York provides welcome news on pain relief for mesothelioma patients. The research, published in the journal JAMA Oncology, shows that the use of acupuncture reduces chronic musculoskeletal pain in cancer survivors more effectively than traditional treatments, including pain medication, physical therapy and
-
Study of Electromagnetic Fields May Benefit Mesothelioma Patients
A study of electromagnetic fields and their effect on cancer metastasis specifically focused on breast cancer cells, but its authors believe that the technology may have an impact on many types of highly metastatic cancers, including malignant mesothelioma. The research was conducted by scientists from the department of mechanical and aerospace engineering at The Ohio
-
Mesothelioma Blamed on Gloves and Boards Used While Making Stained Glass
There are many industries and jobs that are traditionally associated with exposure to asbestos – and subsequently with a mesothelioma diagnosis – but making stained glass is not an occupation that immediately comes to mind. Still, according to Michael A. Love’s survivors, his career in the stained-glass industry put him in direct contact with asbestos
-
Researchers Study Pandemic’s Impact on Screening for Mesothelioma and Other Cancers
Though the pandemic is not yet fully in the rear-view mirror, the availability of three different vaccines is making a big difference, especially for those at risk for malignant mesothelioma. The elderly men and women with a history of exposure to asbestos are among the first group to be eligible for immunizations, and once they
-
Is Minimally Invasive Mesothelioma Surgery a Possibility?
When it comes to surgery for malignant mesothelioma, patients have few options. The procedure is generally done for either curative purposes – to remove as much cancerous tissue as possible in order to prolong life – or palliative purposes, to remove enough of the disease’s tumors to provide relief from pressure on organs and improve
-
Maryland Mesothelioma Victims See Chance for Compensation Diminished
A multi-year backlog of lawsuits against asbestos product companies is being winnowed down as many cases are being dropped or dismissed, leaving victims of mesothelioma, asbestosis, and other serious diseases with little recourse and high levels of frustration. The unfortunate outcome follows refusal on the part of legislators and the judiciary to agree to consolidating
-
Study Criticizes Selective Use of Data Regarding Asbestos Dangers
A recently published study published in the Journal of Occupational Medicine and Toxicology highlights the challenges faced by those trying to link asbestos exposure to malignant mesothelioma. According to two noted experts in environmental and occupational health, asbestos industry lobbyists selectively use data and disinformation to minimize the mineral’s risks.
-
Former Boilermaker Seeking $27 Million in Compensation for Mesothelioma
A Seattle jury heard closing arguments this week in a mesothelioma lawsuit that pitted a former boilermaker against Pryor Giggey, Co. The victim’s attorney built a case showing that the company had manufactured asbestos-contaminated boiler refractory insulation to which Cliff Little had been exposed while working at Puget Sound Naval Shipyard.
-
Improper Witness Testimony Leads to Mesothelioma Retrial
A recent mesothelioma lawsuit accused Johnson & Johnson and Colgate-Palmolive of negligently allowing their talcum powder products to be contaminated with asbestos, leading to the untimely death of Donna Hayes. Though the jury found the companies blameless, Mrs. Hayes’ family appealed that decision on the basis of improper witness testimony that they’d unsuccessfully tried to
-
FDG-PET Radiomic Modeling Helps Predict Mesothelioma Outcomes
With the help of advanced imaging techniques and computer modeling, Swiss physicians believe that they’ve found a more effective way of predicting the progression of pleural mesothelioma tumors. Their innovation combines the power of FDG-PET scans and advanced computer programming.
-
Retrospective Study Confirms Superiority of Less Aggressive Mesothelioma Surgery
Patients facing the grim outlook of a malignant pleural mesothelioma diagnosis are faced with a series of difficult treatment decision. Among the most challenging is whether to undergo an extremely aggressive form of surgery that sacrifices one of their lungs or a less aggressive-but-easier-to-tolerate procedure that leaves their lung and much of their thoracic tissue
-
Could Red Ginseng Slow Mesothelioma’s Spread?
An ingredient in traditional Korean medicine has been found to inhibit lung cancer metastasis, and future research may reveal that the same is true for malignant mesothelioma and other cancers. The discovery is yet another example of how traditional Korean and Chinese medicines may have functional use in the treatment of disease and in improved
-
UK Mesothelioma Victim Files Suit Against Sir Richard Branson
A 74-year-old former shop fitter from the United Kingdom has filed a mesothelioma lawsuit against Sir Richard Branson, the billionaire and former owner of Virgin Records. According to the claim, Bernard Jones had worked on the first retail space for the iconic record store and was exposed to asbestos while doing demolition and installation work.
-
Testimony in Asbestos Lawsuit Reveals the Pain and Grief of Mesothelioma
Mesothelioma lawsuits tend to focus on how the victim was exposed to asbestos and whether enough of the carcinogen was present to have led to their fatal illness. But testimony heard yesterday via Zoom made clear that the real issue at the heart of each case is the pain and loss faced by every family
-
Study Confirms Positive Effects of Mesothelioma Surgery After Radiotherapy
Finding the right treatment protocol for the treatment of malignant pleural mesothelioma is an ongoing project, with researchers around the world working diligently to identify the correct combination of treatments, in the right order, to deliver the best overall survival. A recent study published in the renowned journal The Lancet Oncology has revealed that patients undergoing the most
